• 2019
  Delville M, Touzot F, Couzin C, Hmitou I, Djerroudi L, Ouedrani A, Lefrère F, Tuchman-Durand C, Mollet C, Fabreguettes JR, Ferry N, Laganier L, Magnani A, Magrin E, Jolaine V, Saez-Cirion A, Wolstein O, Symonds G, Frange P, Moins-Teisserenc H, Chaix-Baudier ML, Toubert A, Larghero J, Parquet N, Brignier AC, Barré-Sinoussi F, Oksenhendler E, Cavazzana M, Safety of CD34 Hematopoietic Stem Cells and CD4 T Lymphocytes Transduced with LVsh5/C46 in HIV-1 Infected Patients with High-Risk Lymphoma, Mol Ther Methods Clin Dev 2019 Jun;13:303-309.
• 2016
  Ploquin MJ, Madec Y, Casrouge A, Huot N, Passaes C, Lécuroux C, Essat A, Boufassa F, Jacquelin B, Jochems SP, Petitjean G, Angin M, Gärtner K, Garcia-Tellez T, Noël N, Booiman T, Boeser-Nunnink BD, Roques P, Saez-Cirion A, Vaslin B, Dereudre-Bosquet N, Barré-Sinoussi F, Ghislain M, Rouzioux C, Lambotte O, Albert ML, Goujard C, Kootstra N, Meyer L, Müller-Trutwin MC, , Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset., PLoS Pathog 2016 08; 12(8): e1005774.
• 2016
  Hamimi C, David A, Versmisse P, Weiss L, Bruel T, Zucman D, Appay V, Moris A, Ungeheuer MN, Lascoux-Combe C, Barré-Sinoussi F, Muller-Trutwin M, Boufassa F, Lambotte O, Pancino G, Sáez-Cirión A, , , Dendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 Particles., PLoS One 2016 ; 11(8): e0160251.
• 2015
  Moreno-Nieves UY, Didier C, Lévy Y, Barré-Sinoussi F, Scott-Algara D,, S100A9 Tetramers, Which are Ligands of CD85j, Increase the Ability of MVAHIV-Primed NK Cells to Control HIV Infection, Front Immunol 2015;6:478.
• 2015
  Boender TS, Barré-Sinoussi F, Cooper D, Goosby E, Hankins C, Heidenrijk M, de Jong M, Kazatchkine M, Laoye F, Merson M, Reiss P, Rinke de Wit TF, Rogo K, Schellekens O, Schultsz C, Sigaloff KC, Simon J, Zewdie D, Research in action: from AIDS to global health to impact. A symposium in recognition of the scientific contributions of Professor Joep Lange, Antivir. Ther. (Lond.) 2015;20(1):101-8.
• 2015
  Zeisel MB, Lucifora J, Mason WS, Sureau C, Beck J, Levrero M, Kann M, Knolle PA, Benkirane M, Durantel D, Michel ML, Autran B, Cosset FL, Strick-Marchand H, Trépo C, Kao JH, Carrat F, Lacombe K, Schinazi RF, Barré-Sinoussi F, Delfraissy JF, Zoulim F, Towards an HBV cure: state-of-the-art and unresolved questions–report of the ANRS workshop on HBV cure, Gut 2015 Aug;64(8):1314-26.
• 2015
  Bruel T, Hamimi C, Dereuddre-Bosquet N, Cosma A, Shin SY, Corneau A, Versmisse P, Karlsson I, Malleret B, Targat B, Barré-Sinoussi F, Le Grand R, Pancino G, Sáez-Cirión A, Vaslin B, Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses, J. Virol. 2015 Apr;89(7):3542-56.
• 2015
  Jochems SP, Petitjean G, Kunkel D, Liovat AS, Ploquin MJ, Barré-Sinoussi F, Lebon P, Jacquelin B, Müller-Trutwin MC, , Modulation of type I interferon-associated viral sensing during acute simian immunodeficiency virus infection in African green monkeys., J Virol 2015 Jan; 89(1): 751-62.
• 2014
  Quillay H, El Costa H, Marlin R, Duriez M, Cannou C, Chrétien F, Fernandez H, Lebreton A, Ighil J, Schwartz O, Barré-Sinoussi F, Nugeyre MT, Menu E, , Distinct characteristics of endometrial and decidual macrophages and regulation of their permissivity to HIV-1 infection by SAMHD1., J Virol 2015 Jan; 89(2): 1329-39.
• 2014
  Tucker JD, Volberding PA, Margolis DM, Rennie S, Barré-Sinoussi F, Words matter: Discussing research towards an HIV cure in research and clinical contexts, J. Acquir. Immune Defic. Syndr. 2014 Nov;67(3):e110-1.
• 2014
  Barré-Sinoussi F, Gomez-Touriño I, Q&A: Françoise Barré-Sinoussi. HIV adversary, Nature 2014 Oct;514(7522):S8-9.
• 2014
  Chevalier MF, Didier C, Petitjean G, Karmochkine M, Girard PM, Barré-Sinoussi F, Scott-Algara D, Weiss L, Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells, J. Infect. Dis. 2015 Mar;211(5):769-79.
• 2014
  Cummings JS, Moreno-Nieves UY, Arnold V, Gilbert A, Yarbrough K, Didier C, Lévy Y, Barré-Sinoussi F, Scott-Algara D,, Natural killer cell responses to dendritic cells infected by the ANRS HIV-1 vaccine candidate, MVAHIV, Vaccine 2014 Sep;32(43):5577-84.
• 2014
  Beyrer C, Crago AL, Bekker LG, Butler J, Shannon K, Kerrigan D, Decker MR, Baral SD, Poteat T, Wirtz AL, Weir BW, Barré-Sinoussi F, Kazatchkine M, Sidibé M, Dehne KL, Boily MC, Strathdee SA, An action agenda for HIV and sex workers, Lancet 2015 Jan;385(9964):287-301.
• 2014
  Lewin SR, Deeks SG, Barré-Sinoussi F, Towards a cure for HIV–are we making progress?, Lancet 2014 Jul;384(9939):209-11.
• 2014
  Duriez M, Quillay H, Madec Y, El Costa H, Cannou C, Marlin R, de Truchis C, Rahmati M, Barré-Sinoussi F, Nugeyre MT, Menu E, Human decidual macrophages and NK cells differentially express Toll-like receptors and display distinct cytokine profiles upon TLR stimulation, Front Microbiol 2014;5:316.
• 2014
  Jacquelin B, Petitjean G, Kunkel D, Liovat AS, Jochems SP, Rogers KA, Ploquin MJ, Madec Y, Barré-Sinoussi F, Dereuddre-Bosquet N, Lebon P, Le Grand R, Villinger F, Müller-Trutwin M, , Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferon-alpha during primary SIVagm infection., PLoS Pathog 2014 Jul; 10(7): e1004241.
• 2014
  Moreno-Nieves UY, Didier C, Lévy Y, Barré-Sinoussi F, Scott-Algara D,, NK cells are primed by ANRS MVA(HIV)-infected DCs, via a mechanism involving NKG2D and membrane-bound IL-15, to control HIV-1 infection in CD4+ T cells, Eur. J. Immunol. 2014 Aug;44(8):2370-9.
• 2014
  Allouch A, David A, Amie SM, Lahouassa H, Chartier L, Margottin-Goguet F, Barré-Sinoussi F, Kim B, Sáez-Cirión A, Pancino G, Reply to Pauls et al.: p21 is a master regulator of HIV replication in macrophages through dNTP synthesis block, Proc. Natl. Acad. Sci. U.S.A. 2014 Apr;111(14):E1325-6.
• 2014
  Saez-Cirion A, Jacquelin B, Barré-Sinoussi F, Müller-Trutwin M, , Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?, Philos Trans R Soc Lond B Biol Sci 2014 ; 369(1645): 20130436.
• 2013
  Arnold V, Cummings JS, Moreno-Nieves UY, Didier C, Gilbert A, Barré-Sinoussi F, Scott-Algara D, S100A9 protein is a novel ligand for the CD85j receptor and its interaction is implicated in the control of HIV-1 replication by NK cells, Retrovirology 2013;10:122.
• 2013
  Hamimi C, Pancino G, Barré-Sinoussi F, Sáez-Cirión A, Will it be possible to live without antiretroviral therapy?, Curr Opin HIV AIDS 2013 May;8(3):196-203.
• 2013
  Lederman MM, Barre-Sinoussi F, Who would have thought?, Curr Opin HIV AIDS 2013 May;8(3):163-4.
• 2012
  , Deeks SG, Autran B, Berkhout B, Benkirane M, Cairns S, Chomont N, Chun TW, Churchill M, Di Mascio M, Katlama C, Lafeuillade A, Landay A, Lederman M, Lewin SR, Maldarelli F, Margolis D, Markowitz M, Martinez-Picado J, Mullins JI, Mellors J, Moreno S, O'Doherty U, Palmer S, Penicaud MC, Peterlin M, Poli G, Routy JP, Rouzioux C, Silvestri G, Stevenson M, Telenti A, Van Lint C, Verdin E, Woolfrey A, Zaia J, Barré-Sinoussi F, Towards an HIV cure: a global scientific strategy, Nat. Rev. Immunol. 2012 Aug;12(8):607-14.
• 2012
  Deeks SG, Barré-Sinoussi F, Public health: Towards a cure for HIV, Nature 2012 Jul;487(7407):293-4.
• 2012
  Ploquin MJ, Jacquelin B, Jochems SP, Barré-Sinoussi F, Müller-Trutwin MC, , Innate immunity in the control of HIV/AIDS: recent advances and open questions., AIDS 2012 Jun; 26(10): 1269-79.
• 2012
  Pean P, Nerrienet E, Madec Y, Borand L, Laureillard D, Fernandez M, Marcy O, Sarin C, Phon K, Taylor S, Pancino G, Barré-Sinoussi F, Scott-Algara D,, Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis, Blood 2012 Apr;119(14):3315-20.
• 2012
  Petitjean G, Chevalier MF, Tibaoui F, Didier C, Manea ME, Liovat AS, Campa P, Müller-Trutwin M, Girard PM, Meyer L, Barré-Sinoussi F, Scott-Algara D, Weiss L, , Level of double negative T cells, which produce TGF-β and IL-10, predicts CD8 T-cell activation in primary HIV-1 infection., AIDS 2012 Jan; 26(2): 139-48.
• 2012
  Marlin R, Duriez M, Berkane N, de Truchis C, Madec Y, Rey-Cuille MA, Cummings JS, Cannou C, Quillay H, Barré-Sinoussi F, Nugeyre MT, Menu E, Dynamic shift from CD85j/ILT-2 to NKG2D NK receptor expression pattern on human decidual NK during the first trimester of pregnancy, PLoS ONE 2012;7(1):e30017.
• 2012
  Liovat AS, Rey-Cuillé MA, Lécuroux C, Jacquelin B, Girault I, Petitjean G, Zitoun Y, Venet A, Barré-Sinoussi F, Lebon P, Meyer L, Sinet M, Müller-Trutwin M, , Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection., PLoS One 2012 ; 7(10): e46143.
• 2011
  Sáez-Cirión A, Hamimi C, Bergamaschi A, David A, Versmisse P, Mélard A, Boufassa F, Barré-Sinoussi F, Lambotte O, Rouzioux C, Pancino G,, Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers, Blood 2011 Jul;118(4):955-64.
• 2009
  Jacquelin B, Mayau V, Targat B, Liovat AS, Kunkel D, Petitjean G, Dillies MA, Roques P, Butor C, Silvestri G, Giavedoni LD, Lebon P, Barré-Sinoussi F, Benecke A, Müller-Trutwin MC, , Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response., J Clin Invest 2009 Dec; 119(12): 3544-55.
• 2008
  Scott-Algara D, Arnold V, Didier C, Kattan T, Pirozzi G, Barré-Sinoussi F, Pancino G, The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cells, PLoS ONE 2008;3(4):e1975.
• 2007
  Sáez-Cirión A, Lacabaratz C, Lambotte O, Versmisse P, Urrutia A, Boufassa F, Barré-Sinoussi F, Delfraissy JF, Sinet M, Pancino G, Venet A,, HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype, Proc. Natl. Acad. Sci. U.S.A. 2007 Apr;104(16):6776-81.
• 2006
  Beq S, Nugeyre MT, Ho Tsong Fang R, Gautier D, Legrand R, Schmitt N, Estaquier J, Barré-Sinoussi F, Hurtrel B, Cheynier R, Israël N, IL-7 induces immunological improvement in SIV-infected rhesus macaques under antiviral therapy, J. Immunol. 2006 Jan;176(2):914-22.
• 2005
  Kornfeld C, Ploquin MJ, Pandrea I, Faye A, Onanga R, Apetrei C, Poaty-Mavoungou V, Rouquet P, Estaquier J, Mortara L, Desoutter JF, Butor C, Le Grand R, Roques P, Simon F, Barré-Sinoussi F, Diop OM, Müller-Trutwin MC, , Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS., J Clin Invest 2005 Apr; 115(4): 1082-91.
• 2004
  Ploquin MJ, Diop OM, Sol-Foulon N, Mortara L, Faye A, Soares MA, Nerrienet E, Le Grand R, Van Kooyk Y, Amara A, Schwartz O, Barré-Sinoussi F, Müller-Trutwin MC, , DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus SIVagm., J Virol 2004 Jan; 78(2): 798-810.
• 2003
  Scott-Algara D, Truong LX, Versmisse P, David A, Luong TT, Nguyen NV, Theodorou I, Barré-Sinoussi F, Pancino G, Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users, J. Immunol. 2003 Dec;171(11):5663-7.
• 2001
  Lagaye S, Derrien M, Menu E, Coïto C, Tresoldi E, Mauclère P, Scarlatti G, Chaouat G, Barré-Sinoussi F, Bomsel M,, Cell-to-cell contact results in a selective translocation of maternal human immunodeficiency virus type 1 quasispecies across a trophoblastic barrier by both transcytosis and infection, J. Virol. 2001 May;75(10):4780-91.
• 1999
  Menu E, Mbopi-Keou FX, Lagaye S, Pissard S, Mauclère P, Scarlatti G, Martin J, Goossens M, Chaouat G, Barré-Sinoussi F, M'bopi Kéou FX, Selection of maternal human immunodeficiency virus type 1 variants in human placenta. European Network for In Utero Transmission of HIV-1, J. Infect. Dis. 1999 Jan;179(1):44-51.
• 1994
  Estaquier J, Idziorek T, de Bels F, Barré-Sinoussi F, Hurtrel B, Aubertin AM, Venet A, Mehtali M, Muchmore E, Michel P, Mouton Y, Girard M, Ameisen JC, Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections, Proc. Natl. Acad. Sci. U.S.A. 1994 Sep;91(20):9431-5.
• 1992
  Fultz PN, Nara P, Barre-Sinoussi F, Chaput A, Greenberg ML, Muchmore E, Kieny MP, Girard M, Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells, Science 1992 Jun;256(5064):1687-90.
• 1990
  Darlix JL, Gabus C, Nugeyre MT, Clavel F, Barré-Sinoussi F, Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1, J. Mol. Biol. 1990 Dec;216(3):689-99.
• 1984
  Alizon M, Sonigo P, Barré-Sinoussi F, Chermann JC, Tiollais P, Montagnier L, Wain-Hobson S, Molecular cloning of lymphadenopathy-associated virus, Nature 1984 Dec 20-1985 Jan 2;312(5996):757-60.
• 1984
  Brun-Vezinet F, Rouzioux C, Barre-Sinoussi F, Klatzmann D, Saimot AG, Rozenbaum W, Christol D, Gluckmann JC, Montagnier L, Chermann JC, Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome, Lancet 1984 Jun;1(8389):1253-6.
• 1983
  Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vézinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L, Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS), Science 1983 May;220(4599):868-71.